Alan B Lancz & Associates, Inc.
Source: SEC Form 13F · as of Mar 2026Alan B Lancz & Associates, Inc. holds 12 biotech & pharma companies tracked by BioSniper, totaling $11.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$11.7M
| Company | Shares | Value |
|---|---|---|
| AMGNAMGEN INC | 9,730 | $3.4M |
| MRKMerck & Co., Inc. | 11,973 | $1.4M |
| JNJJOHNSON & JOHNSON | 5,537 | $1.4M |
| LLYELI LILLY & Co | 1,415 | $1.3M |
| GILDGILEAD SCIENCES, INC. | 7,990 | $1.1M |
| ABBVAbbVie Inc. | 4,402 | $957K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 8,750 | $483K |
| ZTSZoetis Inc. | 3,575 | $423K |
| PFEPFIZER INC | 13,194 | $370K |
| BMYBRISTOL MYERS SQUIBB CO | 5,550 | $337K |
| ZBHZimmer Biomet Holdings Inc. | 3,600 | $326K |
| JAZZJazz Pharmaceuticals plc | 1,075 | $203K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.